Weill Cornell’s UAEM students have helped to add simvastatin to the WHO’s list of essential medicines:
“In a move to improve global public health, Weill Cornell Medical College students have helped place a lifesaving heart disease drug onto the World Health Organization’s (WHO) list of essential medicines. This list is a guideline for developing countries to […]

Writing on the occassion of thee BIO conference in Boston and professor Jim Kim’s National Day of Action address at Harvard, the Globe highlighted UAEM’s proposals as one of the key ways to ensure that new biotechnology advances are “not just for the rich.” The full text of the editorial is after the jump.
Other prominent […]

UAEM, along with University of Wisconsin students from SGAC, AMSA, and the UW Global Health Interest Group, sent the following public letter on April 26th to the Wisconsin Alumni Research Foundation (WARF), the licensing arm of the University of Wisconsin. The letter was sent to coincide with the international actions protesting Abbott’s withdrawal of […]

This panel at Harvard Law School convened noted scientists, university administrators, IP lawyers and public health experts in a discussion of how university licensing practices can be changed to promote greater global access to university-researched medicine. This event was sponsored by Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics in collaboration with Ethics, […]